Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism DCN1 inhibitors(Defective cullin neddylation protein 1 inhibitors), UBC12 modulators(ubiquitin conjugating enzyme E2 M modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC31H47N5O4S |
InChIKeyCNJKDQGPBAWNRY-IZZNHLLZSA-N |
CAS Registry2245887-38-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 27 Oct 2017 |